Anzeige
Mehr »
Login
Mittwoch, 06.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
4.000 Meilen, um herauszufinden, warum der „Warren Buffett des Bergbaus“ in diese Kupferaktie investierte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CWHD | ISIN: US88583P1049 | Ticker-Symbol: 8LL
Frankfurt
06.11.24
15:29 Uhr
1,250 Euro
+0,160
+14,68 %
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
374WATER INC Chart 1 Jahr
5-Tage-Chart
374WATER INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,3901,43016:31
ACCESSWIRE
144 Leser
Artikel bewerten:
(0)

374Water Inc.: 374Water Expands Operations Capabilities with State-of-the-Art Biosafety Level 1 Laboratory

DURHAM, NC / ACCESSWIRE / November 6, 2024 /

374Water Inc. (NASDAQ:SCWO), an emerging leader in organic waste destruction solutions for the municipal, federal and industrial sectors, has significantly enhanced its capabilities with the expansion into a new, state-of-the-art laboratory facility in Morrisville, NC. This new space, built to Biosafety Level 1 (BSL-1) standards, enables the Company to conduct advanced research for customers on the destruction capabilities of its proprietary AirSCWO technology on a broad range of organic waste and contaminants.

AirSCWO harnesses the power of supercritical water oxidation to destroy organic waste streams resulting in clean mineral water, effluent and recoverable heat energy. AirSCWO eliminates recalcitrant wastes, including emerging contaminants like PFAS, without creating waste byproducts.

The 3,500-square-foot custom-built lab more than triples 374Water's treatment and testing capacity, accelerating processing speed and expanding the range of hazardous waste materials that can be evaluated and processed, marking a pivotal step in the company's growth and laying the groundwork for potential long-term partnerships with prospective municipal, federal and industrial customers.

"Our expanded laboratory facility represents a major leap forward in our testing capabilities and throughput, which should allow us to penetrate a growing number of markets in need of advanced waste solutions," said Chris Gannon, CEO of 374Water. "This facility enables us to work with more complex materials and positions us at the cutting edge of research and development in our industry, enabling us to meet growing demand for testing on a broad array of organic waste streams."

The new location in the Southport Innovation Center also positions 374Water alongside companies with overlapping interests, generating new opportunities, potential partnerships, and visibility for the industry.

Looking ahead, 374Water plans to continue expanding operations at the new site. A second bench-scale reactor is expected to come online by the end of 2024, further enhancing the company's treatability studies and extending its mobile capabilities with the addition of a custom-built trailer for off-site client work. The Company plans to further expand lab testing, analysis, and research capabilities in 2025.

For more information about 374Water and its innovative waste destruction technology, visit www.374water.com.

About 374Water

374Water Inc. (Nasdaq:SCWO) is a global cleantech company providing innovative solutions addressing wastewater treatment and waste management issues within the municipal, federal and industrial markets. 374Water's AirSCWO technology is designed to efficiently destroy and mineralize a broad spectrum of organic non-hazardous and hazardous organic wastes producing safe dischargeable water streams, safe mineral effluent, safe vent gas, and recoverable heat energy. 374Water's AirSCWO technology has the potential to assist its customers to meet discharge requirements, reduce or eliminate disposal costs, remove bottlenecks, and reduce litigation and other risks. 374Water continues to be a leader in innovative waste treatment solutions, dedicated to creating a greener future and eradicating harmful pollutants. Learn more by visiting www.374water.com and follow us on LinkedIn.

Cautionary Language on Forward-Looking Statements

Certain statements in this communication are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements relate to future events or our future financial performance, including statements relating to our ability accelerate processing speeds and expand the types of waste materials we can evaluate and process, and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or our achievements or those of our industry to be materially different from those expressed or implied by any forward-looking statements. In some cases, forward-looking statements may be identified by the use of words like "forward," "begin," "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "project," "consider," "predict," "potential," "feel," or other comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates, beliefs, and projections. While the Company believes these expectations, assumptions, estimates, and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control. These and other important factors, including those discussed under "Risk Factors" in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, as well as the Company's subsequent filings with the SEC, may cause actual results, performance, or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements herein are made only as of the date they were first issued, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Investor Contact:
Heather Crowell
ir@374water.com

Media Contact:
Christian Rizzo
media@374water.com

SOURCE: 374Water Inc.



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.